News
ABT
114.23
+1.61%
1.81
Love Dividends? 2 Passive Income Stocks to Scoop Up Now.
Barchart · 1d ago
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
Seeking Alpha · 2d ago
My Top 10 Stocks to Buy for 2025
The Motley Fool · 2d ago
Analysts Are Bullish on These Healthcare Stocks: Veru (VERU), Ascendis Pharma (ASND)
TipRanks · 2d ago
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
NASDAQ · 3d ago
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
NASDAQ · 3d ago
Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?
Barchart · 3d ago
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
NASDAQ · 3d ago
4 Healthcare Technology Innovators to Invest in Before the New Year
NASDAQ · 4d ago
ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSM
NASDAQ · 4d ago
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
The Motley Fool · 4d ago
Abbott Laboratories (ABT) Gets a Buy from Piper Sandler
TipRanks · 4d ago
This is why you should turn defensive, underweight cyclicals – UBS
Seeking Alpha · 4d ago
Least shorted S&P 500 stocks in November
Seeking Alpha · 5d ago
5 Dividend Aristocrats Where Analysts See Capital Gains
NASDAQ · 5d ago
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
NASDAQ · 5d ago
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
NASDAQ · 5d ago
Reasons to Add McKesson Stock to Your Portfolio Right Now
NASDAQ · 5d ago
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?
Barchart · 5d ago
The Smartest Dividend Stocks to Buy With $500 Right Now
NASDAQ · 5d ago
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.